LINC02334

Across TCGA pan-cancer cohorts, LINC02334 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of LINC02334’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where LINC02334 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02334 is over-expressed in tumor, although a few such as KIRP and KIRC show the opposite, repressed pattern.

KIRP, KIRC, and BLCA are the cancer types where LINC02334 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02334 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	Male	II,III,IV	−1.072	<.001	9	view →
KIRC	Male	All	−0.515	<.001	9	view →
BLCA	Male	III,IV	−0.885	.017	6	view →
THCA	All	All	−0.085	<.001	4	view →
LUSC	All	II,III,IV	−0.071	<.001	4	view →
LIHC	All	All	+0.024	.004	4	view →
CHOL	All	II,III,IV	+0.085	.003	3	view →
COAD	Female	All	+0.043	.013	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

LINC02334–KIRP

Open the KIRP breakdown →